XML 41 R20.htm IDEA: XBRL DOCUMENT
v3.25.2

Share-Based Compensation | 12 Months Ended
--- | ---
Jun. 30, 2025
Share-Based Payment Arrangement [Abstract] |
Share-Based Compensation | 15. Share-Based Compensation We maintain Cardinal Health, Inc. stock incentive plans (collectively, the “Plans”) for the benefit of certain of our officers, directors, and employees. Upon vesting these units convert to common shares without restrictions or future service requirements. At June 30, 2025, 15 million shares remain available for future grants under the Cardinal Health, Inc. 2021 Long-Term Incentive Plan ("2021 LTIP"). Under the 2021 LTIP's fungible share counting provisions, stock options are counted against the plan as one share for every share issued; awards other than stock options are counted against the plan as two and one-half shares for every share issued. This means that only 6 million shares could be issued under awards other than stock options while 15 million shares could be issued under stock options. Shares are issued out of treasury shares when stock options are exercised and when restricted share units and performance share units vest. Until the end of fiscal 2018, stock options were granted to our officers and certain employees. There were no stock options granted to employees during fiscal 2025, 2024, or 2023. During fiscal 2024, we modified the equity incentive awards of four employees to amend provisions over involuntary termination. We recognized incremental share-based compensation expense of $9 million. The following table provides total share-based compensation expense by type of award:
(in millions) | 2025 |  | 2024 |  | 2023
Restricted share unit expense | $ | 71 |  |  | $ | 77 |  |  | $ | 64 |
Performance share unit expense | 50 |  |  | 44 |  |  | 32 |
Total share-based compensation expense | $ | 121 |  |  | $ | 121 |  |  | $ | 96 |
The total tax benefit related to share-based compensation was $14 million, $16 million, and $12 million for fiscal 2025, 2024, and 2023, respectively. Share-based compensation expense is included in selling, general, and administrative expenses in the consolidated statements of earnings. Our consolidated statements of cash flows present our share-based compensation expense as a reconciling adjustment between net income and net cash provided by operating activities for all periods presented. Restricted Share Units Restricted share units granted under the Plans generally vest in equal annual installments over three years. Restricted share units accrue cash dividend equivalents that are payable upon vesting of the awards. The following table summarizes all transactions related to restricted share units under the Plans:
(in millions, except per share amounts) | Restricted Share Units |  | Weighted-Average Grant Date Fair Value per Share
Nonvested at June 30, 2023 | 2.2 |  |  | $ | 57.37 |
Granted | 0.9 |  |  | 91.06 |
Vested | (1.2) |  |  | 60.47 |
Canceled and forfeited | (0.2) |  |  | 74.40 |
Nonvested at June 30, 2024 | 1.7 |  |  | 70.98 |
Granted | 0.7 |  |  | 108.72 |
Vested | (0.9) |  |  | 72.07 |
Canceled and forfeited | (0.1) |  |  | 94.67 |
Nonvested at June 30, 2025 | 1.4 |  |  | $ | 86.30 |
The following table provides additional data related to restricted share unit activity:
(in millions) | 2025 |  | 2024 |  | 2023
Total compensation cost, net of estimated forfeitures, related to nonvested restricted share and share unit awards not yet recognized, pre-tax | $ | 64 |  |  | $ | 71 |  |  | $ | 73 |
Weighted-average period in years over which restricted share and share unit cost is expected to be recognized (in years) | 2 |  | 2 |  | 2
Total fair value of shares vested during the year | $ | 60 |  |  | $ | 63 |  |  | $ | 58 |
Performance Share Units Performance share units generally vest over a three-year performance period based on achievement of specific performance goals. Based on the extent to which the performance goals are achieved and the Company's TSR relative to the S&P 500 Health Care Index, vested shares may range from zero to 240 percent of the target award amount. Performance share units accrue cash dividend equivalents that are payable upon vesting of the awards. The following table summarizes all transactions related to performance share units under the Plans (based on target award amounts):
(in millions, except per share amounts) | Performance Share Units |  | Weighted-Average Grant Date Fair Value per Share
Nonvested at June 30, 2023 | 1.2 |  |  | $ | 82.17 |
Granted | 0.5 |  |  | 94.66 |
Vested | (0.4) |  |  | 62.26 |
Canceled and forfeited | — |  |  | — |
Nonvested at June 30, 2024 | 1.3 |  |  | 97.03 |
Granted | 0.5 |  |  | 113.88 |
Vested | (0.3) |  |  | 108.79 |
Canceled and forfeited | — |  |  | — |
Nonvested at June 30, 2025 | 1.5 |  |  | $ | 99.45 |
The following table provides additional data related to performance share unit activity:
(in millions) | 2025 |  | 2024 |  | 2023
Total compensation cost, net of estimated forfeitures, related to nonvested performance share units not yet recognized, pre-tax | $ | 47 |  |  | $ | 46 |  |  | $ | 38 |
Weighted-average period over which performance share unit cost is expected to be recognized (in years) | 2 |  | 2 |  | 2
Total fair value of shares vested during the year | $ | 49 |  |  | $ | 20 |  |  | $ | 23 |
Employee Retirement Savings Plans Substantially all of our domestic non-union employees are eligible to be enrolled in our company-sponsored contributory retirement savings plans, which include features under Section 401(k) of the Internal Revenue Code of 1986 and provide for matching and discretionary contributions by us. The total expense for our employee retirement savings plans was $89 million, $65 million, and $66 million for fiscal 2025, 2024, and 2023, respectively.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration